Mobile

A randomized, international, open-label, phase II study of peripheral blood progenitor cell (PBPC) mobilization and engraftment with pegfilgrastim or filgrastim for autologous transplantation in subje...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-000891-34

A randomized, international, open-label, phase II study of peripheral blood progenitor cell (PBPC) mobilization and engraftment with pegfilgrastim or filgrastim for autologous transplantation in subjects with multiple myeloma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate engraftment of PBPC’s mobilized by two different fixed doses of pegfilgrastim and a by-weight dose of filgrastim

Critère d'inclusion

  • Multiple myeloma

Liens